Correlation of Interleukin-33 and Imunoglobulin E with Risk of Asthma in Pregnant Woman
Main Article Content
Abstract
Background: Interleukin-33 (Il-33) is involved in the pathogenesis of atopic asthma by activating Th2 cells. Immunoglobulin E (IgE) attached to mast cells and degranulation which cause bronchoconstriction, mucus secretion and vasodilation in asthma. The pathomechanism of asthma in pregnancy not clearly understood. The main of this study to evaluate the level of IL-33 and IgE in asthma pregnancy.
Method: This was a case control study conducted in Makassar Indonesia from November 2020 until June 2021. Interleukin 33 and IgE levels were analyzed from serum samples using the Enzyme-linked Immunosorbent Assay (ELISA) method and the level of asthma control determined with GINA Criteria
Result: Subject were 80 pregnant women: 40 subject with asthma in pregnancy and 40 non asthma. Subject of asthma in pregnancy were 22 uncontrolled, 18 well controlled asthma. The mean age was not significantly different between the subjects of pregnant women with asthma (28.025 + 5.17 years) and subjects of non-asthmatic pregnant women (28.025 + 4.26 years). Mean serum IL-33 levels were not higher in pregnant women with asthma than non-asthmatic pregnant women (1.77 vs 1.60 рg/mL, p=0.43) but mean serum IgE level were higher (529.8 vs 66.77 IU/mL, p=0.001). Mean serum IL-33 levels were not higher in uncontrolled asthma compared to well controlled (1.62 vs 1.98 рg/mL, p=0.44) but mean serum IgE levels were higher in uncontrolled asthma compared to controlled asthma (745.76 vs 264.6 IU/mL, p=0.01).
Conclusion: Levels of IL-33 serum were not higher asthma in pregnancy and also not different in level of asthma controlled, but levels IgE serum were higher in subjects with asthma in pregnancy and also uncontrolled asthma.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Barman R, MT Alam, MMSU Islam, AM Hossain4, SAM Ahmed, SA Fattah, M yusuf Ali. Treating Asthma in Pregnancy - An Update. Faridpur Med. Coll. J. 2013;8(2):85-91
II. Murphy VE, Clifton VL, Gibson PG (2006) Asthma exacerbations during pregnancy: incidence and association with adverse pregnancy outcomes. Thorax 61(2):169–176
III. Wang G, Murphy VE, Namazy J, Powell H, Schatz M, Chambers C, et al. The risk of maternal and placental complications in pregnant women with asthma: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2014;27(9):934–42
IV. Yagami A, Orihara K, Morita H, Futamaru K (2010). IL-33 Mediates Inflammatory Responses in Human Lung Tissue Cells. J Immunol 185: 5743-5750Thomas A. The Role of Immunoglobulin E in Allergy and Asthma. American Jour Crit Care Med 2001;1-7
V. Lee M. Perry, Dennis R. Ownby, Ganesa R. Differences in total and allergen-specific IgE during pregnancy compared to 1 month and 1 year postpartum. Ann Allergy Asthma Immunol. 2009; 103(4): 342–347
VI. Gaga M, E. Oikonomidou, E. Zervas. Asthma and pregnancy: interactions and management. Breathe March 2007 Volume 3; 3: 267
VII. Larry Borish, John W. Steinke. Interleukin-33 in Asthma: How Big of a Role Does It Play. Curr Allergy Asthma Rep. 2011 Feb; 11(1): 7–11.
VIII. Amina Hamed, Abdul Ghani, Abdul Kareem, Jasim Mohammad. The Predictive Value of IgE as Biomarker in Asthma. Journal of Asthma, 45:654–663, 2008 Rui Li, Gang Yang, Ruiqi Yang, Xiaoxing Peng, Jing Li. Interleukin-33 and receptor ST2 as indicators in patients with asthma: a meta-analysis. Int J Clin Exp Med 2015;8(9):14935-14943 Ingrid Granne,Jennifer H. Southcombe, James V. Snider, Dionne S. Tannetta, Tim Child, Christopher W. G. Redman, and Ian L. Sargent. ST2 and IL-33 in Pregnancy and Pre-Eclampsia. PLoS One. 2011; 6(9): e24463.
IX. Cai Y. • Zhou J. • Webb D.C. Estrogen Stimulates Th2 Cytokine Production and Regulates the Compartmentalisation of Eosinophils during Allergen Challenge in a Mouse Model of Asthma. Arch Allergy Immunol 2012;158: 252–260
X. Larry Borish, John W. Steinke. Interleukin-33 in Asthma: How Big of a Role Does It Play. Curr Allergy Asthma Rep. 2011 Feb; 11(1): 7–11.